Streetbeat News

Stock Prices

ECDA

ECD Automotive Design has regained compliance with Nasdaq and will list its shares on the Nasdaq Capital Market starting September 13, 2024. The company transferred its listing to meet the $35 million MVLS requirement.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:37 am

DOYU

TME

WBTN

The article highlights three oversold stocks in the communication services sector with potential for short-term gains: Tencent Music Entertainment Group (TME), Douyu International Holdings Ltd (DOYU), and Webtoon Entertainment Inc (WBTN). These stocks have RSI values below 30, indicating they are oversold. TME reported a slight revenue decline and missed analyst estimates, while DOYU and WBTN also reported revenue declines and missed expectations. Despite recent stock price declines, these companies may present buying opportunities.

Portfolio Pulse from Avi Kapoor

September 16, 2024 | 11:35 am

JAZZ

Jazz Pharmaceuticals released updated data from a Phase 2 trial of Zanidatamab, showing promising results in combination with chemotherapy for treating HER2-expressing advanced or metastatic gastroesophageal adenocarcinoma.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:35 am

CKPT

Checkpoint Therapeutics presented longer-term data from its pivotal trial of Cosibelimab, an anti-PD-L1 antibody, for treating locally advanced and metastatic cutaneous squamous cell carcinoma at the ESMO Annual Congress.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:34 am

SBT

Trading for a company has been halted at 7:25 a.m. ET due to pending news. This typically indicates significant news is forthcoming, which could impact the stock price once trading resumes.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:25 am

AAPL

Apple shares fell in premarket trading due to lower-than-expected iPhone 16 preorders, competition in China, and broader market concerns. Analyst Ming-Chi Kuo reported a 12.7% drop in preorders compared to the iPhone 15, citing weak demand for the Pro series and competition from Huawei.

Portfolio Pulse from Shanthi Rexaline

September 16, 2024 | 11:17 am

ZNTL

Zentalis Pharmaceuticals announced that it is on track to meet its previously disclosed data guidance for the rest of 2024. The company plans to present data on azenosertib monotherapy and provide updates on its clinical development at a corporate event later this year.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:08 am

ASND

Ascendis Pharma released positive topline data from the ApproaCH trial for Transcon CNP, showing improved growth velocity in children with achondroplasia compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:08 am

STEM

Stem Inc. has appointed David Buzby as interim CEO following the departure of John Carrington. Buzby will also continue as Executive Chair. The company is finalizing its strategy review and will announce the results soon. Finding a new permanent CEO is crucial for executing the new strategy.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:07 am

PDSB

PDS Biotechnology Corporation announced promising results from its VERSATILE-002 trial, showing that its Versamune HPV in combination with KEYTRUDA® significantly improves survival rates and response rates in HPV16-positive head and neck cancer patients. The trial results were presented at the ESMO Congress 2024, and a Phase 3 trial is planned.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:06 am